To explore whether the methylation status of both CD133 and CD147, as potential biomarkers, have an impact on the overall survival of patients with OSCC, we subtracted the patients with OSCC from the TCGA HNSCC cohort and well-annotated clinical data that could be correlated with survival and gene methylation status. Here, BSG is linked to head and neck squamous cell carcinoma.